Pain Management Therapeutics Market Will Become Worth US$88,253.4 Million by 2025, Says TMR

News provided by

Transparency Market Research

29 Jan, 2019, 10:00 GMT

ALBANY, New York, January 29, 2019 /PRNewswire/ --

The TMR report projects the global pain management therapeutics market to register a promising CAGR of 4.0% from 2017 to 2025. By the end of 2025, the market will be worth US$88,253.4 million, predicts the report.

     (Logo: https://mma.prnewswire.com/media/664869/Transparency_Market_Research_Logo.jpg )

Out of the various disease indications, the demand for cancer pain management is expected to remain high in the next few years with rising cases of cancer along with increasing awareness about cancer pain therapeutics. Region wise, North America is expected to lead the global pain management therapeutics market in the coming years. This is attributed to increased reimbursement policies for prescription drugs for pain management in the region.

Get PDF Brochure for Research Insights at https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=1059

Growing Population Suffering from Chronic Pain to Boost Pain Management Therapeutics Market 

As per U.S Institute of Medicine, approximately 100 million adults in 2011, suffered from chronic conditions such as migraine pain, low back pain, and neck pain. The number of patients suffering from chronic pain is rising constantly. This increased patient base affects worker productivity, negatively impacts the patients' financial and emotional state, and increases the healthcare costs. Increasing economic stability across the globe, and raising and improving healthcare infrastructure are factors fueling the demand in global pain management therapeutics market. Along with this, rapid changing lifestyles, burgeoning population, and rising cases of chronic pain globally are driving the global pain management therapeutics market.

Request a Sample of Report at https://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=1059

Furthermore, there are many pain management therapeutics available in the market in the form of anticonvulsants, anesthetics, non-steroidal anti-inflammatory drugs (NSAIDS), opioids, and antidepressants. People across the world are suffering from various types of pain such as arthritic pain, chronic back pain, cancer pain, fibromyalgia, and neuropathic pain. Rising prescription of opioids for pain relieving, increasing population suffering from cancer pain, and growing incidence of low back pain due to low desk jobs are also boosting the global pain management therapeutics market.

Slow Penetration of Newly Launched Pain Management Drugs Hinders Market Growth  

A few challenges hindering the growth in the global pain management therapeutics market are stringent regulations in using opioids in certain countries, and the huge time taken in launching pain management drugs to penetrate the market. Nonetheless, rising usage of pain management therapeutics for relieving pain is expected to help overcome some of these challenges.

Request For Discount On This Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=D&rep_id=1059

Transparency Market Research (TMR) notes that the global pain management therapeutics market is categorized by the presence of several large and small players operating in it. The rivalry between the potential players is likely to increase as they aim at adopting various strategies to offer a large volume of pain management drugs at cheaper costs.

Among multiple strategies adopted by players in the global pain management therapeutics market to stay ahead of the competitors, branding innovation has paid off the most. The global pain management therapeutics market is expected to grow steadily due to the existence of potential large players who are heavily investing in research and development activities to launch a new drug for pain management. Some of the leading players in the global collaborative robot market are Abbott Laboratories, AstraZeneca, Endo Health Solutions, Novartis AG, and Teva Pharmaceuticals.

Browse Press Release - https://www.transparencymarketresearch.com/pressrelease/pain-management-therapeutics.htm

The information presented in this review is based on a TMR report, titled "Pain Management Therapeutics Market (Therapeutics - Anticonvulsants, Antidepressants, Anesthetics, Non-steroidal Anti-inflammatory Drugs (NSAIDS), Opioids, Other Non-narcotic Analgesic, and Antimigraine Agents; Indication - Neuropathic Pain, Fibromyalgia, Arthritic Pain, Chronic Back Pain, Migraine, Post-Operative Pain, and Cancer Pain) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025'.

Popular Research Reports by TMR: 

About Us 

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company's exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR's experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information.

TMR's data repository is continuously updated and revised by a team of research experts so that it always reflects the latest trends and information. With extensive research and analysis capabilities, Transparency Market Research employs rigorous primary and secondary research techniques to develop distinctive data sets and research material for business reports.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com

Website: http://www.transparencymarketresearch.com
Research Blog: https://theglobalhealthnews.com/